Hypogonadism: Clinical Trials

79 trials for Hypogonadism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

53 completed, 7 recruiting, 6 withdrawn, 5 terminated. 79 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 479Completed 53, Recruiting 7, Withdrawn 6, Terminated 5, Unknown 5, Not yet recruiting 3

Follow Hypogonadism: new trials by email Literature Review of Hypogonadism trials Research Report on Hypogonadism

Trials (filtered) newest first · largest first

All 79 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Testosterone cypionate - Prostate Cancer, Hypogonadism, Male
Phase 4RecruitingUniversity of Miami352026-11-302026-11-02
Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
Testosterone Cypionate Injection 200 mg/mL - Hypogonadism, Male
Phase 4Not yet recruitingAzurity Pharmaceuticals1442026-02-012026-01-09
Tirzepatide in PWS, HO and GNSO
Tirzepatide - Prader-Willi Syndrome, Hypothalamic Obesity
Phase 4RecruitingGrace Kim362025-05-012025-09-16
Peri-Operative Testosterone Administration in Primary Hip Arthroscopy
Nandrolone Decanoate, Saline - Femoro Acetabular Impingement
Phase 4Not yet recruitingAmerican Hip Institute602025-01-012025-01-01
Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty
Nandrolone decanoate, Saline - Osteoarthritis, Hip
Phase 4Not yet recruitingAmerican Hip Institute602025-01-012025-01-01
Klinefelter Syndrome and Testosterone Treatment in Puberty
Testosterone gel, Placebo - Klinefelter Syndrome
Phase 4RecruitingLise Aksglæde322024-08-152025-02-19
Adaptions and Resiliency to Multi-Stressor OpeRations
Goserelin 3.6 MG, Multi-Stressor Training, Testosterone gel (AndroGel 5g) - Musculoskeletal Injury, Hypogonadism
Phase 4RecruitingBradley Nindl1202024-07-152026-08-18
A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months
Jatenzo Oral Product - Hypogonadism
Phase 4CompletedTolmar Inc.1162024-07-022026-10-02
Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome
Fenofibrate 145 mg - Klinefelter Syndrome
Phase 4UnknownUniversity of Colorado, Denver442022-11-032024-10-16
Natesto Spermatogenesis Reboot
NatestoTM - Hypogonadism, Male
Phase 4CompletedUniversity of Florida132022-06-012025-06-13
Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
Testosterone Undecanoate, Placebo - Fatty Liver, Overweight/Obesity
Phase 4RecruitingAlexandra Kautzky-Willer322022-01-252024-03-13
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome
17-beta estradiol - Turner Syndrome, Hypogonadism; Ovarian
Phase 4RecruitingAarhus University Hospital502021-11-292024-08-26
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
17-beta estradiol - Turner Syndrome, Hypogonadism; Ovarian
Phase 4RecruitingAarhus University Hospital502021-11-292024-08-23
A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial
Letrozole 2.5mg, hCG, Placebo - Hypogonadism, Hypogonadism, Male
Phase 4TerminatedCopenhagen University Hospital, Rigshospitalet82021-11-242024-02-15
A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel
Natesto - Hypogonadism
Phase 4UnknownAcerus Pharmaceuticals Corporation2182021-07-012022-07-06
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
Atorvastatin 40 Mg Oral Tablet - Diabetes Mellitus, Type 2, Dyslipidemia Associated With Type II Diabetes Mellitus
Phase 4CompletedHopital La Rabta1042021-03-012023-04-10
Testosterone in Bariatric Patients
Testosterone Undecanoate - Bariatric Surgery Candidate, Male Hypogonadism
Phase 4CompletedEsbjerg Hospital - University Hospital of Southern Denmark642020-12-172026-09-11
Vogelxo(R) ABPM Study in Hypogandal Men
Vogelxo - Hypogonadism, Male
Phase 4CompletedUpsher-Smith Laboratories1222020-08-282024-10-18
A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections
Testosterone Cypionate 200 Mg/ML, Intranasal Testosterone - Hypogonadism, Male
Phase 4CompletedUniversity of Miami812020-08-072023-12-13
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
Aveed Injectable Product, Fortesta, Testim - Hypogonadism, Hypogonadism, Male
Phase 4CompletedEndo USA Inc., a Keenova Therapeutics Company6732020-06-302025-03-14

Showing 20 of 79. Sign in to see all of them.

Narrower conditions

Eunuchism (14)  ·  Obesity (10)  ·  Diabetes Mellitus, Type 2 (8)  ·  Insulin Resistance (7)  ·  Metabolic Syndrome (7)  ·  Diabetes Mellitus (6)  ·  Klinefelter Syndrome (4)  ·  Inflammation (3)  ·  Kallmann Syndrome (3)  ·  Turner Syndrome (3)  ·  Erectile Dysfunction (2)  ·  Fatty Liver (2)  ·  Gonadal Disorders (2)  ·  Prostatic Hyperplasia (2)

Broader conditions

Endocrine System Diseases (78)  ·  Gonadal Disorders (77)  ·  Nutritional and Metabolic Diseases (26)  ·  Glucose Metabolism Disorders (20)  ·  Metabolic Diseases (20)  ·  Male Urogenital Diseases (19)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Urogenital Diseases (19)  ·  Signs and Symptoms (15)  ·  Congenital Abnormalities (12)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Disorders of Sex Development (12)  ·  Female Urogenital Diseases (12)  ·  Female Urogenital Diseases and Pregnancy Complications (12)

Interventions

Testosterone (32)  ·  Testosterone Propionate (10)  ·  testosterone undecanoate (10)  ·  testosterone 17 beta-cypionate (5)  ·  Chorionic Gonadotropin (4)  ·  Estradiol (4)  ·  Injections (4)  ·  Natesto (4)  ·  Sodium Chloride (3)  ·  Adenosine Monophosphate (2)  ·  Anastrozole (2)  ·  Dutasteride (2)  ·  Gels (2)  ·  Menotropins (2)  ·  Nandrolone Decanoate (2)

Sponsors

Gulhane School of Medicine (8)  ·  University of Colorado, Denver (4)  ·  University of Miami (3)  ·  Aarhus University Hospital (2)  ·  AbbVie (2)  ·  Acerus Pharmaceuticals Corporation (2)  ·  American Hip Institute (2)  ·  Barnsley Hospital (2)  ·  Bayer (2)  ·  Baylor College of Medicine (2)  ·  Marianne Andersen (2)  ·  Men's Health Boston (2)  ·  University Medical Centre Ljubljana (2)  ·  University at Buffalo (2)  ·  University of Roma La Sapienza (2)

Countries

United States (38)  ·  Denmark (9)  ·  Turkey (Türkiye) (8)  ·  United Kingdom (5)  ·  China (3)  ·  Italy (3)  ·  Austria (2)  ·  Germany (2)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Latvia (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Russia (1)

Top investigators

Abraham Morgentaler, MD (3)  ·  Claus H Gravholt, Professor (2)  ·  Ranjith Ramasamy, MD (2)  ·  Shalender Bhasin, MD (2)  ·  Shanlee M Davis, MD (2)  ·  Alexandra Kautzky-Willer, MD (1)  ·  Alvin M Matsumoto, MD (1)  ·  Andrea Lenzi, MD, PhD (1)  ·  Andrea M Isidori, MD, PhD (1)  ·  Andrej Janez, MD, PhD (1)  ·  Anna Chan (1)  ·  Apichat Kongkanand, Professor (1)  ·  Aydogan Aydogdu, MD (1)

Results publications

PMID 28981994, PMID 11502778, PMID 11836290, PMID 17983892, PMID 18996225, PMID 19394149, PMID 19707253, PMID 19732305, PMID 20200299, PMID 20592293, PMID 21575967, PMID 21697501, PMID 21738005, PMID 21880799, PMID 22010203, PMID 23292288, PMID 23482592, PMID 23678038, PMID 23730808, PMID 24089589, PMID 24134648, PMID 25825944, PMID 26262795, PMID 26622051, PMID 26892583, PMID 27377542, PMID 27754805, PMID 27992261, PMID 28168203, PMID 28938446, PMID 28950424, PMID 29373734, PMID 29656500, PMID 29846604, PMID 30629183, PMID 31858126, PMID 31996919, PMID 32250330, PMID 32499757, PMID 32853647, PMID 33537757, PMID 33718653, PMID 33728428, PMID 33813517, PMID 34412687, PMID 35027909, PMID 35665818, PMID 36171900, PMID 37126399, PMID 37326322

NIH funding

2009 (2), 2008 (1), 2017 (1), 2018 (1), 2023 (1), I01CX001665 (1), K12HD057022 (1), K23HD092588 (1), R01DK075877 (1), R01HD093047 (1), U01AG014369 (1), UL1TR001082 (1)